# US 2016/0250476 A1 · Therapy program selection for electrical stimulation therapy based on a volume of tissue activation

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2016/0250476 A1
- Document ID: US20160250476A1
- Status: Published application
- Kind: A1
- Application number: 15/044,795
- Filed: 2016-02-16
- Published: 2016-09-01
- Earliest claimed: 2015-02-26
- Assignees: Medtronic, Inc.
- Applicants: Medtronic, Inc.
- Inventors: William F. Kaemmerer; Maciej T. Lazarewicz; Gabriela C. Molnar; Ashutosh Chaturvedi
- Web page: https://patentgrep.com/patent/US20160250476A1

## CPC

- A61N 1/3614: {based on impedance measurement}
- A61N 1/36185: {Selection of the electrode configuration}
- A61N 1/37247: {User interfaces, e.g. input or presentation means}
- G16H 20/30: relating to physical therapies or activities, e.g. physiotherapy, acupressure or exercising
- G16H 20/40: relating to mechanical, radiation or invasive therapies, e.g. surgery, laser therapy, dialysis or acupuncture
- G16H 50/30: for calculating health indices; for individual health risk assessment
- A61N 1/3605: {Implantable neurostimulators for stimulating central or peripheral nerve system}
- A61N 1/36082: {Cognitive or psychiatric applications, e.g. dementia or Alzheimer's disease}
- A61N 1/36128: {Control systems}
- A61N 1/36182: {Direction of the electrical field, e.g. with sleeve around stimulating electrode}
- G16H 50/50: for simulation or modelling of medical disorders
- A61N: ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY (measurement of bioelectric currents A61B; surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body A61B18/00; anaesthetic apparatus in general A61M; incandescent lamps H01K; infrared radiators for heating H05B)
- G16H: HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA

## Abstract

In some examples, a processor of a system evaluates a therapy program based on a score determined based on a volume of tissue expected to be activated (“VTA”) by therapy delivery according to the therapy program. The score may be determined using a three-dimensional (3D) grid comprising a plurality of voxels that are each assigned a value. The processor may register the VTA with the 3D grid and determine the score for the therapy program based on the values assigned to voxels with which the VTA overlaps. One or more therapy programs for electrical stimulation therapy (e.g., deep brain stimulation) may be selected based on the scores determined based on the 3D grid.

## Claims

### Claim 1

A method comprising:
determining, by a processor, values for a plurality of voxels of a three-dimensional grid, wherein determining the values comprises:
determining a volume of tissue activation (VTA) expected to result from delivery of electrical stimulation by a medical device according to a therapy program;
registering the VTA to the three-dimensional grid;
determining a frequency domain characteristic of a bioelectrical brain signal of a patient sensed during delivery of electrical stimulation to the patient by the medical device according to the therapy program; and
determining a value for at least one of the voxels overlapping with the VTA based on the frequency domain characteristic of the bioelectrical brain signal.

### Claim 2 (depends on 1)

The method of claim 1, wherein determining the value for the at least one voxel comprises:
determining a change in the frequency domain characteristic of the bioelectrical brain signal relative to a baseline value of the frequency domain characteristic; and
determining the value based on the determined change.

### Claim 3 (depends on 1)

The method of claim 1,
wherein determining the VTA comprises determining a plurality of VTAs, wherein each VTA is expected to result from delivery of electrical stimulation according to a respective therapy program of the plurality of therapy programs, each VTA being associated with the respective therapy program,
wherein determining the frequency domain characteristic of the bioelectrical brain signal comprises determining frequency domain characteristics of each bioelectrical brain signal of a plurality of bioelectrical brain signals, wherein each bioelectrical brain signal is sensed during delivery of electrical stimulation to the patient by the medical device according to a respective therapy program of the plurality of therapy programs, each bioelectrical brain signal being associated with the respective therapy program,
wherein the at least one voxel overlaps with at least two VTAs of the plurality of VTAs, and
wherein determining the value of the at least one voxel comprises determining the value based on the frequency domain characteristics of the bioelectrical brain signals associated with the therapy programs associated with the at least two VTAs.

### Claim 4 (depends on 3)

The method of claim 3, wherein each therapy program of the plurality of therapy programs has the same electrode combination.

### Claim 5 (depends on 3)

The method of claim 3, wherein determining the value based on the frequency domain characteristics of the bioelectrical brain signals associated with the therapy programs associated with the at least two VTAs comprises assigning the at least one voxel a mean, a median, a lowest value, or a highest value of the frequency domain characteristics.

### Claim 6 (depends on 1)

The method of claim 1, wherein the frequency domain characteristic comprises at least one of: a change in a power level in a frequency band of interest of the bioelectrical brain signal relative to a baseline power level, or the power level in the frequency band of interest.

### Claim 7 (depends on 1)

The method of claim 1, wherein the VTA comprises a first VTA, the therapy program comprises a first therapy program, and the frequency domain characteristic of the bioelectrical brain signal comprises a first frequency domain characteristic of a first bioelectrical brain signal, the method further comprising:
determining a second VTA expected to result from delivery of electrical stimulation by the medical device according to a second therapy program;
determining a second frequency domain characteristic of a second bioelectrical brain signal of the patient sensed during delivery of electrical stimulation to the patient by the medical device according to the second therapy program; and
updating the values for the plurality of voxels of the three-dimensional grid based on the second VTA and the second frequency domain characteristic.

### Claim 8 (depends on 7)

The method of claim 7, wherein the first therapy program has a different electrode combination, a different stimulation amplitude, or both a different electrode combination and a different stimulation amplitude than the second therapy program.

### Claim 9 (depends on 1)

The method of claim 1, wherein the VTA comprises a first VTA and determining the frequency domain characteristic comprises determining a power level in a frequency band of interest of the bioelectrical brain signal, the method further comprising:
determining an incremental change in the power level in the frequency band of interest relative to a stored power level associated with a previously tested therapy program;
determining a number of voxels of the 3D grid that are included in the first VTA and are not in a second VTA determined based on the previously tested therapy program; and
determining a credit-per-voxel based on the number of voxels that are included in the first VTA and not in the second VTA, and based on the incremental change in the power level in the frequency band of interest relative to the stored power level,
wherein determining the value for the at least one voxel comprises assigning each voxel included in the first VTA and not in a second VTA a greater of the credit-per-voxel or a previously determined value for the voxel.

### Claim 10 (depends on 9)

The method of claim 9, wherein the credit-per-voxel equals the incremental change in the power level in the frequency band of interest relative to the stored power level divided by the number of voxels.

### Claim 11 (depends on 9)

The method of claim 9, wherein the frequency domain characteristic comprises a first frequency domain characteristic, the bioelectrical brain signal comprises a first bioelectrical brain signal, and the therapy program comprises a first therapy program, the method further comprising:
selecting the first therapy program, wherein selecting the therapy program comprises:
selecting a first electrode; and
selecting an electrical stimulation amplitude value,
after determining the value for at least one voxel overlapping with the first VTA, increasing the electrical stimulation amplitude value;
determining, by the processor, the increased electrical stimulation amplitude value is less than a predetermined maximum electrical stimulation amplitude value; and
in response to determining the increased electrical stimulation amplitude value is less than the predetermined maximum electrical stimulation amplitude value:
determining a third VTA expected to result from delivery of electrical stimulation according to a second therapy program including the first electrode and the increased electrical stimulation amplitude value;
determining a second frequency domain characteristic of a second bioelectrical brain signal of the patient sensed during delivery of electrical stimulation to the patient by the medical device according to the second therapy program; and
determining values for voxels of the 3D grid overlapping with the third VTA based on the second frequency domain characteristic of the second bioelectrical brain signal.

### Claim 12 (depends on 9)

The method of claim 9, wherein the frequency domain characteristic comprises a first frequency domain characteristic, the bioelectrical brain signal comprises a first bioelectrical brain signal, and the therapy program comprises a first therapy program, the method further comprising:
selecting the first therapy program, wherein selecting the therapy program comprises:
selecting a first electrode; and
selecting a first electrical stimulation amplitude value;
after determining the value for at least one voxel overlapping with the first VTA, increasing the first electrical stimulation amplitude value;
determining, by the processor, the increased first electrical stimulation amplitude value is greater than a predetermined maximum electrical stimulation amplitude value;
in response to determining the increased first electrical stimulation amplitude value is greater than the predetermined maximum electrical stimulation amplitude value, determining there is a second electrode to test to assign values to the voxels of the 3D grid; and
in response to determining there is a second electrode to test:
determining a third VTA expected to result from delivery of electrical stimulation according to a second therapy program including the second electrode and a second electrical stimulation amplitude value;
determining a second frequency domain characteristic of a second bioelectrical brain signal of the patient sensed during delivery of electrical stimulation to the patient by the medical device according to the second therapy program; and
determining values for voxels of the 3D grid overlapping with the third VTA based on the second frequency domain characteristic of the second bioelectrical brain signal.

### Claim 13 (depends on 1)

The method of claim 1, wherein the therapy program comprises a first therapy program and the VTA comprises a first VTA, the method further comprising evaluating, by the processor, a second therapy program based on the values of the voxels, wherein evaluating the second therapy program comprises:
determining a second VTA expected to result from delivery of electrical stimulation according to the second therapy program;
registering the second VTA to the three-dimensional grid; and
determining a score for the second therapy program based on the values of the voxels that overlap with the second VTA.

### Claim 14 (depends on 1)

The method of claim 1, further comprising evaluating, by the processor, a plurality of therapy programs based on the values of the voxels of the three-dimensional grid, wherein evaluating the plurality of therapy programs comprises:
for each of the therapy programs of the plurality of therapy programs, determining a VTA expected to result from delivery of electrical stimulation according to the respective therapy program;
registering each of the VTAs to the three-dimensional grid;
for each of the therapy programs of the plurality of therapy programs, determining a score based on the values of the voxels that overlap with the respective VTA; and
selecting, by the processor, at least one of the therapy programs of the plurality of therapy programs based on the scores.

### Claim 15 (depends on 14)

The method of claim 14, further comprising programming, by the processor, the medical device with the selected at least one of the therapy programs.

### Claim 16 (depends on 14)

The method of claim 14, further comprising:
presenting, via a user interface, a list comprising the plurality of therapy programs and respective scores; and
ordering the plurality of therapy programs within the list based on the scores.

### Claim 17 (depends on 1)

The method of claim 1, wherein determining the VTA comprises:
generating a general VTA based on a general electrical field model that includes tissue conductance values not specific to a patient; and
scaling the general VTA based on a scaling factor to generate a patient-specific VTA.

### Claim 18 (depends on 1)

The method of claim 1, further comprising controlling electrical stimulation therapy delivered to a patient by the medical device based on the values of the voxels.

### Claim 19 (depends on 1)

The method of claim 1, further comprising, presenting, via a display device, a user interface that is generated based on the values of the voxels.

### Claim 20

A system comprising:
a memory that stores a three-dimensional grid comprising a plurality of voxels; and
a processor configured to determine values for the plurality of voxels by at least:
determining a volume of tissue activation (VTA) expected to result from delivery of electrical stimulation by a medical device according to a therapy program,
registering the VTA to the three-dimensional grid,
determining a frequency domain characteristic of a bioelectrical brain signal of a patient sensed during delivery of electrical stimulation to the patient by the medical device according to the therapy program, and
determining a value for at least one voxel overlapping with the VTA based on the frequency domain characteristic of the bioelectrical brain signal,
wherein the processor is further configured to store the determined values in the memory.

### Claim 21 (depends on 20)

The system of claim 20, wherein the processor is configured to determine the value for the at least one voxel by at least:
determining a change in the frequency domain characteristic of the bioelectrical brain signal relative to a baseline value of the frequency domain characteristic, and
determining the value based on the determined change.

### Claim 22 (depends on 20)

The system of claim 20, wherein the processor is configured to determine the VTA by at least determining a plurality of VTAs, wherein each VTA is expected to result from delivery of electrical stimulation according to a respective therapy program of the plurality of therapy programs, each VTA being associated with the respective therapy program,
wherein the processor is configured to determine the frequency domain characteristic by at least determining frequency domain characteristics of each bioelectrical brain signal of a plurality of bioelectrical brain signals, wherein each bioelectrical brain signal is sensed during delivery of electrical stimulation to the patient by the medical device according to a respective therapy program of the plurality of therapy programs, each bioelectrical brain signal being associated with the respective therapy program,
wherein the at least one voxel overlaps with at least two VTAs of the plurality of VTAs, and
wherein the processor is configured to determine the value of the at least one voxel based on the frequency domain characteristics of the bioelectrical brain signals associated with the therapy programs associated with the at least two VTAs.

### Claim 23 (depends on 22)

The system of claim 22, wherein each therapy program of the plurality of therapy programs has the same electrode combination.

### Claim 24 (depends on 22)

The system of claim 22, wherein the processor is configured to determine the value based on the frequency domain characteristics of the bioelectrical brain signals associated with the therapy programs associated with the at least two VTAs by at least assigning the at least one voxel a mean, a median, a lowest value, or a highest value of the frequency domain characteristics.

### Claim 25 (depends on 20)

The system of claim 20, wherein the frequency domain characteristic comprises at least one of: a change in a power level in a frequency band of interest of the bioelectrical brain signal relative to a baseline power level, or the power level in the frequency band of interest.

### Claim 26 (depends on 20)

The system of claim 20, wherein the VTA comprises a first VTA, the therapy program comprises a first therapy program, and the frequency domain characteristic of the bioelectrical brain signal comprises a first frequency domain characteristic of a first bioelectrical brain signal, and wherein the processor is further configured to determine a second VTA expected to result from delivery of electrical stimulation according to a second therapy program, determine a second frequency domain characteristic of a second bioelectrical brain signal of the patient sensed during delivery of electrical stimulation to the patient by the medical device according to the second therapy program, and update the values for the plurality of voxels of the three-dimensional grid based on the second VTA and the second frequency domain characteristic.

### Claim 27 (depends on 26)

The system of claim 26, wherein the first therapy program has a different electrode combination, a different stimulation amplitude, or both a different electrode combination and a different stimulation amplitude than the second therapy program.

### Claim 28 (depends on 20)

The system of claim 20, wherein the VTA comprises a first VTA and determining the frequency domain characteristic comprises determining a power level in a frequency band of interest of the bioelectrical brain signal, and wherein the processor is further configured to determine an incremental change in the power level in the frequency band of interest relative to a stored power level associated with a previously tested therapy program, determine a number of voxels of the 3D grid that are included in the first VTA and are not in a second VTA generated based on the previously tested therapy program, determine a credit-per-voxel based on the number of voxels that are included in the first VTA and not in the second VTA, and based on the incremental change in the power level in the frequency band of interest relative to the stored power level, and determine the value for the at least one voxel by at least assigning each voxel included in the first VTA and not in a second VTA a greater of the credit-per-voxel or a previously determined value for the voxel.

### Claim 29 (depends on 28)

The system of claim 28, wherein the credit-per-voxel equals the incremental change in the power level in the frequency band of interest relative to the stored power level divided by the number of voxels.

### Claim 30 (depends on 20)

The system of claim 20, wherein the frequency domain characteristic comprises a first frequency domain characteristic, the bioelectrical brain signal comprises a first bioelectrical brain signal, and the therapy program comprises a first therapy program, and wherein the processor is further configured to:
select the first therapy program by at least selecting a first electrode and selecting an electrical stimulation amplitude value, and
after determining the value for at least one voxel overlapping with the first VTA, increase the electrical stimulation amplitude value,
determine the increased electrical stimulation amplitude value is less than a predetermined maximum electrical stimulation amplitude value, and
in response to determining the increased electrical stimulation amplitude value is less than the predetermined maximum electrical stimulation amplitude value:
determine a third VTA expected to result from delivery of electrical stimulation according to a second therapy program including the first electrode and the increased electrical stimulation amplitude value;
determine a second frequency domain characteristic of a second bioelectrical brain signal of the patient sensed during delivery of electrical stimulation to the patient by the medical device according to the second therapy program; and
determine values for voxels of the 3D grid overlapping with the third VTA based on the second frequency domain characteristic of the second bioelectrical brain signal.

### Claim 31 (depends on 20)

The system of claim 20, wherein the frequency domain characteristic comprises a first frequency domain characteristic, the bioelectrical brain signal comprises a first bioelectrical brain signal, and the therapy program comprises a first therapy program, and wherein the processor is further configured to:
select the first therapy program by at least selecting a first electrode and selecting a first electrical stimulation amplitude value,
after determining the value for at least one voxel overlapping with the first VTA, increase the first electrical stimulation amplitude value,
determine the increased first electrical stimulation amplitude value is greater than a predetermined maximum electrical stimulation amplitude value,
in response to determining the increased first electrical stimulation amplitude value is greater than the predetermined maximum electrical stimulation amplitude value, determining there is a second electrode to test to assign values to the voxels of the 3D grid, and
in response to determining there is a second electrode to test:
determine a third VTA expected to result from delivery of electrical stimulation according to a second therapy program including the second electrode and a second electrical stimulation amplitude value,
determine a second frequency domain characteristic of a second bioelectrical brain signal of the patient sensed during delivery of electrical stimulation to the patient by the medical device according to the second therapy program, and
determine values for voxels of the 3D grid overlapping with the third VTA based on the second frequency domain characteristic of the second bioelectrical brain signal.

### Claim 32 (depends on 20)

The system of claim 20, wherein the therapy program comprises a first therapy program and the VTA comprises a first VTA, and wherein the processor is further configured to evaluate a second therapy program based on the values of the voxels by at least:
determining a second VTA expected to result from delivery of electrical stimulation according to the second therapy program,
registering the second VTA to the three-dimensional grid, and
determining a score for the second therapy program based on the values of the voxels that overlap with the second VTA.

### Claim 33 (depends on 20)

The system of claim 20, wherein the processor is further configured to evaluate a plurality of therapy programs based on the values of the voxels of the three-dimensional grid by at least:
for each of the therapy programs of the plurality of therapy programs, determining a VTA expected to result from delivery of electrical stimulation according to the respective therapy program,
registering each of the VTAs to the three-dimensional grid, and
for each of the other therapy programs, determining a score based on the values of the voxels that overlap with the respective VTA.

### Claim 34 (depends on 33)

The system of claim 33, further comprising the medical device, wherein the processor is configured to select at least one of the therapy programs of the plurality of therapy programs based on the scores and program the medical device with the selected at least one of the therapy programs.

### Claim 35 (depends on 33)

The system of claim 33, further comprising a user interface, wherein the processor is configured to present, via the user interface, a list comprising the plurality of therapy programs and respective scores, and order the plurality of therapy programs within the list based on the scores.

### Claim 36 (depends on 20)

The system of claim 20, wherein the processor is configured to determine the VTA by at least generating a general VTA based on a general electrical field model that includes tissue conductance values not specific to a patient, and scaling the general VTA based on a scaling factor to generate a patient-specific VTA.

### Claim 37 (depends on 20)

The system of claim 20, further comprising the medical device configured to deliver electrical stimulation therapy to the patient, wherein the processor is configured to control the medical device to deliver the electrical stimulation therapy based on the values of the voxels.

### Claim 38 (depends on 37)

The system of claim 37, wherein the processor is configured to adjust, based on the values of the voxels, one or more electrical stimulation therapy parameters used by the medical device to deliver the electrical stimulation therapy.

### Claim 39 (depends on 37)

The system of claim 37, further comprising a display device, wherein the processor is configured to generate and present, via the display device, a user interface based on the values of the voxels.

### Claim 40

A system comprising:
means for determining values for a plurality of voxels of a three-dimensional grid, wherein the means for determining the values comprises:
means for determining a volume of tissue activation (VTA) expected to result from delivery of electrical stimulation by a medical device according to a therapy program;
means for registering the VTA to the three-dimensional grid;
means for determining a frequency domain characteristic of a bioelectrical brain signal of a patient sensed during delivery of electrical stimulation to the patient by the medical device according to the therapy program; and
means for determining a value for at least one voxel overlapping with the VTA based on the frequency domain characteristic of the bioelectrical brain signal.

### Claim 41 (depends on 40)

The system of claim 40, wherein the VTA comprises a first VTA, the therapy program comprises a first therapy program, and the frequency domain characteristic of the bioelectrical brain signal comprises a first frequency domain characteristic of a first bioelectrical brain signal, the system further comprising:
means for determining a second VTA expected to result from delivery of electrical stimulation according to a second therapy program;
means for determining a second frequency domain characteristic of a second bioelectrical brain signal of the patient sensed during delivery of electrical stimulation to the patient by the medical device according to the second therapy program; and
means for updating the values for the plurality of voxels of the three-dimensional grid based on the second VTA and the second frequency domain characteristic.

### Claim 42 (depends on 40)

The system of claim 40, further comprising:
means for evaluating a plurality of therapy programs based on the values of the voxels of the three-dimensional grid, wherein the means for evaluating the plurality of therapy programs comprises:
means for determining, for each of the therapy programs of the plurality of therapy programs, a VTA expected to result from delivery of electrical stimulation according to the respective therapy program;
means for registering each of the VTAs to the three-dimensional grid; and
means for determining, for each of the other therapy programs a score based on the values of the voxels that overlap with the respective VTA.

### Claim 43

A computer-readable medium comprising instructions that, when executed by a processor, cause the processor to:
determine values for a plurality of voxels of a three-dimensional grid by at least:
determining a volume of tissue activation (VTA) expected to result from delivery of electrical stimulation by a medical device according to a therapy program;
registering the VTA to the three-dimensional grid,
determining a frequency domain characteristic of a bioelectrical brain signal of a patient sensed during delivery of electrical stimulation to the patient by the medical device according to the therapy program; and
determining a value for at least one voxel overlapping with the VTA based on the frequency domain characteristic of the bioelectrical brain signal.

### Claim 44 (depends on 43)

The computer-readable medium of claim 43, further comprising instructions that cause the processor to:
evaluate a plurality of therapy programs based on the values of the voxels of the three-dimensional grid by at least:
determining, for each of the therapy programs of the plurality of therapy programs, a VTA expected to result from delivery of electrical stimulation according to the respective therapy program;
registering each of the VTAs to the three-dimensional grid; and
determining, for each of the other therapy programs a score based on the values of the voxels that overlap with the respective VTA.
